Masumura Kenichi, Toyoda-Hokaiwado Naomi, Niimi Naoko, Grúz Petr, Wada Naoko A, Takeiri Akira, Jishage Kou-Ichi, Mishima Masayuki, Nohmi Takehiko
Division of Genetics and Mutagenesis, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo, 158-8501, Japan.
Research Division, Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka, 412-8513, Japan.
Environ Mol Mutagen. 2017 Dec;58(9):644-653. doi: 10.1002/em.22146. Epub 2017 Oct 27.
DNA polymerase kappa (Polk) is a specialized DNA polymerase involved in translesion DNA synthesis. To understand the protective roles against genotoxins in vivo, we established inactivated Polk knock-in gpt delta (inactivated Polk KI) mice that possessed reporter genes for mutations and expressed inactive Polk. In this study, we examined genotoxicity of benzo[a]pyrene (BP) to determine whether Polk actually suppressed BP-induced genotoxicity as predicted by biochemistry and in vitro cell culture studies. Seven-week-old inactivated Polk KI and wild-type (WT) mice were treated with BP at doses of 5, 15, or 50 mg/(kg·day) for three consecutive days by intragastric gavage, and mutations in the colon and micronucleus formation in the peripheral blood were examined. Surprisingly, no differences were observed in the frequencies of mutations and micronucleus formation at 5 or 50 mg/kg doses. Inactivated Polk KI mice exhibited approximately two times higher gpt mutant frequency than did WT mice only at the 15 mg/kg dose. The frequency of micronucleus formation was slightly higher in inactivated Polk KI than in WT mice at the same dose, but it was statistically insignificant. The results suggest that Polk has a limited ability to suppress BP-induced genotoxicity in the colon and bone marrow and also that the roles of specialized DNA polymerases in mutagenesis and carcinogenesis should be examined not only by in vitro assays but also by in vivo mouse studies. We also report the spontaneous mutagenesis in inactivated Polk KI mice at young and old ages. Environ. Mol. Mutagen. 58:644-653, 2017. © 2017 Wiley Periodicals, Inc.
DNA聚合酶κ(Polκ)是一种参与跨损伤DNA合成的特殊DNA聚合酶。为了解其在体内对基因毒素的保护作用,我们构建了携带突变报告基因并表达无活性Polκ的失活Polκ基因敲入gptδ(失活Polκ KI)小鼠。在本研究中,我们检测了苯并[a]芘(BP)的遗传毒性,以确定Polκ是否真如生物化学和体外细胞培养研究所预测的那样抑制BP诱导的遗传毒性。7周龄的失活Polκ KI小鼠和野生型(WT)小鼠通过灌胃连续三天给予剂量为5、15或50mg/(kg·天)的BP,并检测结肠中的突变和外周血中的微核形成。令人惊讶的是,在5或50mg/kg剂量下,未观察到突变频率和微核形成的差异。仅在15mg/kg剂量时,失活Polκ KI小鼠的gpt突变频率比WT小鼠高约两倍。在相同剂量下,失活Polκ KI小鼠的微核形成频率略高于WT小鼠,但无统计学意义。结果表明,Polκ在抑制结肠和骨髓中BP诱导的遗传毒性方面能力有限,还表明特殊DNA聚合酶在诱变和致癌过程中的作用不仅应通过体外试验,还应通过体内小鼠研究来考察。我们还报告了失活Polκ KI小鼠在幼年和老年时的自发诱变情况。《环境与分子突变》58:644 - 653,2017年。©2017威利期刊公司